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Inhibition of nuclear factor-kB activation reduces cortical
tubulointerstitial injury in proteinuric rats
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Inhibition of nuclear factor-kB activation reduces cortical tu- vine serum albumin, or adriamycin (ADR) [1–3]. In their
bulointerstitial injury in proteinuric rats. early stages, these models are defined by a nonimmune
Background. Protein-induced chemokine expression in proxi- and noninflammatory chronic glomerulopathy in con-mal tubular cells is mediated by the transcription factor nuclear
junction with heavy proteinuria and prominent tubuloin-factor-kappa B (NF-kB). We hypothesized that in vivo inhibi-
terstitial injury [4–6]. The latter is characterized by thetion of renal NF-kB activation would reduce interstitial mono-
cyte infiltration in a rat model of nonimmune proteinuric tubu- presence of tubular damage (atrophy, vacuolization) and
lointerstitial inflammation. a marked interstitial mononuclear inflammatory cell in-
Methods. Male Wistar rats received a single intravenous in-
filtrate composed largely of macrophages and T lympho-jection of doxorubicin hydrochloride [adriamycin (ADR), 7.5
cytes [4–7].mg/kg] and were studied 7, 14, 21, and 28 days later. In a second
study, inhibitors of NF-kB [N-acetylcysteine (NAC; 150 mg/kg, In vitro and in vivo studies strongly support the hypoth-
b.i.d., i.p.), pyrrolidine dithiocarbamate (PDTC, 50 mg/kg, b.i.d., esis that the excess plasma proteins that are present in
i.p.)] or vehicle were commenced on day 14 after the onset of the glomerular ultrafiltrate and their reabsorption byproteinuria and were continued until day 30.
tubular cells are, in part, responsible for the inductionResults. Rats injected with ADR had increased proteinuria
of tubulointerstitial injury in proteinuric models [8–13].(UpV, day 28, 474 6 57; control, 18 6 2 mg/day; P , 0.01) and
cortical tubulointerstitial injury [tubule cell atrophy, interstitial Tubular cells, overloaded with proteins, secrete chemo-
volume, and monocyte/macrophage (ED-1) infiltration]. Elec- tactic and inflammatory mediators that could regulate
trophoretic mobility shift assay of nuclear extracts from whole
the infiltration of inflammatory cells into the interstitiumcortex of ADR rats demonstrated that NF-kB activation (p50/65,
[8–13]. Recently, it was reported that protein-inducedp50/c-Rel) increased from day 7 (4.7 6 0.2 fold-increase above
control; P , 0.01) was maximal at day 28 (6.2 6 0.7; P , 0.01) chemokine production in proximal tubular cells is medi-
and correlated with UpV (r 5 0.63; P , 0.05) and interstitial ated by the transcription factors belonging to the nuclear
ED-1 infiltration (r 5 0.67; P , 0.01). Chronic treatment of
factor-kappa B (NF-kB) family [11, 14]. These ubiqui-ADR rats with PDTC suppressed NF-kB activation (by 73%;
tous transcription factors also up-regulate other inflam-P , 0.05) without any effect on UpV. NF-kB inhibition with
PDTC was accompanied by a reduction in tubule cell atrophy matory mediators, which are overexpressed in the kid-
(59%; P , 0.01), interstitial volume (49%; P , 0.05) and ED-1 neys of proteinuric animals [15–21]. Although the
infiltration (48%; P , 0.01), and cortical lipid peroxidation pathological significance of renal NF-kB activation has(41%; P , 0.05) compared with vehicle-treated ADR rats. In
been documented in experimental models of uretericcontrast NAC had no effect on NF-kB activation, tubulointer-
stitial injury, or UpV in ADR rats. obstruction [22] and immune glomerular injury [23], its
Conclusion. The activation of NF-kB may have an important in vivo role in nonimmune proteinuric renal diseases is
role in mediating cortical interstitial monocyte infiltration and not known.tubular injury in nonimmune proteinuric tubulointerstitial in-
This study was designed to test the hypothesis that theflammation.
activation of NF-kB in the renal cortex mediates the
infiltration of monocytes/macrophages into the cortical
interstitium in a rat model of proteinuric renal disease,Experimental nephrotic syndrome can be induced in
ADR nephrosis. The first aim of this study was to estab-rats with injections of puromycin aminonucleoside, bo-
lish whether NF-kB is activated in the renal cortex of
ADR rats, as well as to determine the relationship, ifKey words: NF-kB, inflammation, monocyte, adriamycin nephrosis,
proteinuria, tubular injury. any, of NF-kB with proteinuria, monocyte/macrophage
infiltration, and tubulointerstitial injury. The second aimReceived for publication November 13, 1998
was to evaluate the effect of NF-kB inhibition on mono-and in revised form February 11, 1999
Accepted for publication February 15, 1999 cyte/macrophage infiltration and tubular injury. For this
purpose, the antioxidant NF-kB inhibitors [24–27] pyr- 1999 by the International Society of Nephrology
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rolidine dithiocarbamate (PDTC) and N-acetylcysteine ADR were stratified into three groups on day 14 ac-
(NAC) were administered to ADR rats with established cording to body weight, baseline endogenous creatinine
proteinuria. clearance (CCl), and UPV. Each group received either
NAC (300 mg/kg/day, N 5 8), PDTC (100 mg/kg/day,
N 5 8), or vehicle (N 5 7) in two divided doses (6 a.m.METHODS
and 6 p.m.) via intraperitoneal injection from day 14
Animals until day 30. Rats were monitored and weighed daily.
Inbred male Wistar rats (six to eight weeks old) were At the end of the study on day 30, nephrectomies were
supplied by the Animal Care Facility, Westmead Hospi- performed as described earlier here approximately three
tal, Sydney, Australia, and were housed under controlled hours after the final injection of NAC or PDTC.
environmental conditions (12 hours of a dark/light cycle, In ADR nephrosis, the severity of the proteinuria and
228C). The animals were allowed free access to standard tubulointerstitial inflammation can be reduced by re-
rat chow (19.0% protein; Glen Forrest Stock, Perth, stricting dietary protein or by administering antioxidants
Australia) and water unless otherwise specified in the prior to or just after disease induction [16, 28]. The latter
experimental protocols. All animals were handled within is thought be due to antioxidant-mediated protection of
the guidelines of the National Health and Medical Re-
the glomerular podocytes against the effects of ADR
search Council of Australia, and protocols were ap-
[28]. To eliminate these factors as possible confoundingproved by the Animal Care and Ethics Committee, West-
variables, all ADR rats were pair fed, and NAC andmead Hospital.
PDTC were commenced on day 14, when proteinuria is
well established [3].Experimental design
N-acetylcysteine and PDTC (Sigma-Aldrich, Sydney,In the first study, the time course of NF-kB activation
Australia) were dissolved in saline under sterile condi-in ADR nephrosis was examined. Rats (the body wt at
tions 30 minutes prior to administration. NAC was neu-the start was 222 to 296 g, and the mean was 261 g,
tralized to pH 7.4 with 6 m sodium hydroxide. ControlN 5 20) received either a single intravenous injection
groups received an equal volume of saline. The doseof doxorubicin hydrochloride (ADR, 7.5 mg/kg; David
and route of administration of NAC and PDTC wereBull Laboratories, Victoria, Australia) or an equal vol-
determined from previous reports [26, 27] and pilot stud-ume of saline (control) while under anesthesia [ket-
ies in ADR rats. Single intraperitoneal doses of NACamine:xylazine, 90 mg/kg:10 mg/kg, intraperitoneal injec-
tion (i.p.i.)] [3]. On days 7, 14, 21, and 28 after injection, (between 200 and 1000 mg/kg) and PDTC (between 50
animals from each group (N 5 4) were anesthetized, and and 200 mg/kg) have been reported to suppress NF-kB
a midline laparotomy was performed. The animals were activation in the lungs of endotoxin-treated rats [26, 27].
killed by exsanguination, and both kidneys were re- However, in pilot studies, total daily doses of NAC ex-
moved, weighed, and processed for various analyses, as ceeding 300 mg/kg caused anorexia and weight loss in
outlined later in this article. These time points were rats with ADR nephrosis, whereas with lower doses, rats
chosen because in previous studies, we found that pro- remained well. With PDTC, a single intraperitoneal dose
teinuria and tubulointerstitial injury were minimal at day of 200 mg/kg was lethal in ADR rats, and between 75
7, mild to moderate at day 14, and severe between days and 150 mg/kg caused dose-dependent acute systemic
21 to 28. Because proteinuria and other parameters were toxicity manifested by generalized seizures, neuromuscu-
not significantly different between individual control ani- lar irritability, and hypersalivation. These effects were
mals, the data from this group were analyzed together. transient, lasting 10 minutes after injection and have
To assess the functional parameters of the model, non-
been reported previously, although only at doses greater
fasting animals were placed in metabolic cages (Tech-
than 450 mg/kg in normal rats [29]. At lower doses ofniplast, Buguggiate, Italy) one day prior to sacrifice for
PDTC (as used in this study), rats developed mild hyper-determination of 24-hour urinary protein (UPV) and cre-
salivation only, lasting 10 minutes after the injection,atinine excretion (UCrV). Venous blood for serum creati-
and the animals remained well in between doses. Tonine (SCr) and albumin (SAlb) was collected at the time
administer total daily doses known to suppress NF-kBof sacrifice.
activation while minimizing the acute toxic effects ofIn the second study, the effect of NAC and PDTC on
PDTC and ensuring constant drugs levels of NAC [26],established ADR nephrosis was evaluated. Rats (the
both drugs were administered twice daily. The reasonsbody wt at the start was 262 to 319 g, mean 283 g, N 5
for the increased sensitivity to the toxic effects of NAC29) were placed in metabolic cages on day 10 after ADR
and PDTC in ADR rats are unknown, but may relateor saline for the determination of baseline UPV and UCrV.
to the use of repeated injections and altered pharmacoki-Venous blood (150 ml) was collected at the end of the
clearance period for SCr and SAlb. Animals injected with netics in the nephrotic syndrome.
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Assessment of renal function
All urine and blood specimens were analyzed by the
Institute of Clinical Pathology and Medical Research,
Westmead Hospital, using a BM/Hitachi 747 analyzer
(Tokyo, Japan). Total protein was analyzed by the Biuret
method [30] and creatinine by the Jaffe kinetic method
without deproteinization [31]. The CCl was calculated
from the UCrV and SCr, and was expressed as milliliter
per minute or milliliter per minute normalized to kidney
weight [32].
Histology and morphometric analysis
Coronal sections of renal tissue were immersion-fixed
in 10% neutral-buffered formalin and embedded in par-
affin. Sections 4 mm thick were stained with periodic
acid-Schiff (PAS). A computer-assisted image analysis
system was used to quantitate glomerular and tubuloin-
terstitial structure in the renal cortex, as described pre-
viously [32]. Sections were viewed with a microscope
(Axioskop; Carl Zeiss Jena GmbH, Jena, Germany), Fig. 1. Method to quantitate the cross-sectional tubular diameter (line
A-C) and tubule cell height (line B-C). Photomicrograph of a proximaland the images were digitalized onto a computer screen
tubule from a periodic acid-Schiff stained section of a normal ratusing a video camera linked to image analysis software (31200).
(Optimas Image Analysis System, version 5.2; Optimas
Corporation, Seattle, WA, USA). To quantitate tubular
atrophy (tubular dilation and tubule cell atrophy), the
cross-sectional diameter and tubule cell height of an indi- The glomerular capillary tuft area (GCA) was mea-
vidual cortical tubule were measured using line morpho- sured by tracing the outline of the capillary tuft (3400)
metric measurements (3400). The tubular diameter was with the mouse and then determining the area (in mm2)
defined as the length of a straight line that passes through as described earlier here. The mesangial matrix area
the center of a symmetrically sectioned tubule and joins (MA) was the PAS-positive intercapillary area divided
two points on the tubular circumference (lines A–C, Fig. by the GCA and expressed as a percentage. To deter-
1). The shortest diameter was selected when the cross mine the glomerular cellularity (GC), each clearly visible
section of the tubule was elliptical in shape. The tubule nucleus within the glomerular capillary tuft was marked
cell height was defined as the distance of a perpendicular on the video screen by point morphometry, and the total
straight line joining two points on the base and apical number was counted. A total of 20 randomly selected
surface of a tubule cell (lines B and C, Fig. 1). A total glomeruli was evaluated, and the mean GCA, MA, and
of 50 randomly selected cortical tubules in 10 nonover- GC were determined per section. All fields for morpho-
lapping fields (3400) was measured, and the mean cross- metric analysis were randomly selected, and the exam-
sectional tubular diameter and tubule cell height were iner of the histological sections was blinded to the experi-
determined for each section.
mental groups.The cortical interstitial volume was defined as the peri-
tubular space and included the tubular basement mem- Immunohistochemistry
brane and peritubular capillaries. The latter were in-
Monocyte/macrophage infiltration was determined bycluded because in preliminary studies we have noted that
immunohistochemical staining for the ED-1 antibody,the interstitial volume expansion in this model is partly
which recognizes a glycoprotein present on the lysosomaldue to tubular basement membrane hypertrophy and neo-
membrane of monocytes and the majority of macrophagesvascularization (unpublished observations). To quantitate
[33]. Immediately after nephrectomy, coronal slices ofthis area, cortical fields (3200) were viewed on a video
each kidney were placed in OCT embedding compoundscreen as described earlier here, and the region occupied
(Tissue-Tek, Sakura Finetek, Torrance, CA, USA), frozenby the interstitial space was carefully traced manually
in liquid nitrogen, sealed with parafilm, and stored atwith a mouse. The area of the traced regions was deter-
2708C. Frozen sections, 6 mm thick, were cut with a cryto-mined with the image analysis software and was ex-
stat (Microm HM 505E; Walldorf, Germany) and placedpressed as a percentage of the total area of the field.
on poly-l-lysine–coated slides. The slides were air driedThe mean percentage area for five nonoverlapping corti-
cal fields was calculated for each section. overnight at room temperature, wrapped in aluminum
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Table 1. Functional parameters in rats injected with adriamycin (ADR)
Body wt Kidney wt Kidney wt:Body wt SCr SA1b V UpV Up:cr CCr
Group N g g/100 g lmol/liter g/liter ml/24 hr mg/24 hr mg/lmol ml/min/g kidney wt
Control 4 354625 0.8960.03 0.25 60.02 5161 2861 31 63 1862 0.1960.01 2.13 60.19
ADR day 7 4 285 67 1.1060.04a 0.3960.00b 4261b 2061b 963b 182644a 2.8560.42b 1.3660.18a
ADR day 14 4 296 66 1.2660.06b 0.4260.02b 4561a 2061b 2062a 444663b 5.3660.37b 1.4760.09a
ADR day 21 4 323 619 1.1760.05a 0.3660.01a 4361b 1861b 2062a 468658b 5.2961.17a 1.5660.23
ADR day 28 4 269 69b 1.3360.06b 0.5060.03a 73610 1661b 1462b 474657b 8.6860.33b 0.6160.13b
Values are expressed as mean 6 sem. Abbreviations are: Body wt, final body weight; Kidney wt, kidney weight; SCr, serum creatinine; SAlb, serum albumin; V,
24-hour urinary volume; UpV, 24-hour urinary protein excretion; Up:cr, urinary protein:creatinine ratio; CCr, endogenous creatinine clearance.
a P , 0.05 and b P , 0.01 when compared to the control group.
foil, and stored at 2708C until immunostaining. Slides Extraction of nuclear proteins from
renal cortical homogenateswere fixed with acetone at 48C for 15 minutes and air
dried for 10 minutes. Nonspecific staining was blocked Cortical renal tissue was carefully dissected from the
with normal rabbit serum (dilution 1:5; Dako Australia, medulla, immediately snap frozen in liquid nitrogen, and
stored at 2708C until further processing. Nuclear proteinSydney, Australia) and blocking buffer (Pierce, Rock-
extracts from cortical tissue were prepared according toford, IL, USA) for 30 minutes each. Sections were incu-
a previous method [27], with some modifications. Onebated with the primary antibody (MCA341, ED-1; dilu-
hundred milligrams of cortical tissue was homogenizedtion, 1:400; Serotec, Oxford, UK) for one hour. As a
with 20 even strokes of a glass Teflon homogenizer innegative control, some sections were incubated with a
200 ml of ice-cold buffer A, composed of 10 mm HEPESmouse IgG1 negative control antibody (MCA1209; Sero-
(pH 7.9), 10 mm KCl, 2 mm MgCl2, and 0.1 mm ethylenedi-tec) at a protein concentration equal to that of the diluted aminetetraacetic acid (EDTA), with a cocktail of prote-
ED-1 antibody. Slides were rinsed in 0.01 m phosphate- ase inhibitors [0.5 mm dithiothreitol, 0.1 mm pepstatin A,
buffered saline (PBS) for 10 minutes in between incuba- 1 mm phenymethylsufonyl fluoride (PMSF), 0.05 mg/ml
tions. Endogenous peroxidase was blocked with 3% leupeptin, and 0.01 mm aprotonin]. Sixty-five microliters
H2O2 for three minutes, after which, slides were rinsed of detergent Nondiet-P40 (2%) were added. The mixture
in distilled water followed by 0.01 m PBS. Antimouse was vortexed 10 times for one minute each, and was
centrifuged at 13,000 g for five minutes. The supernatantrabbit antibody (P0850, 1:50; Dako Australia) in 1%
was removed, and the pellet was resuspended in 60 mlnormal rat serum (X0912; Dako Australia) and mouse
of Buffer B, containing 50 mm HEPES, 10% (vol/vol)peroxidase-antiperoxidase complex (Z0259, 1:100; Dako)
glycerol, 300 mm NaCl, 50 mm KCl, and the proteasewere applied for 25 minutes each. The slides were in-
inhibitor cocktail. It was then vortexed vigorously fivecubated with 3,3-diaminobenzidine tetrahydrochloride
times for two minutes each. The mixture was centrifuged(7.5 mg in 15 ml 0.01 m PBS, 15 ml of 30% H2O2) for 10 at 13,000 g for 10 minutes at 48C. The supernatant was
minutes to produce a dark brown/black–colored end- nuclear protein, and it was diluted to a standard concen-
product. Sections were counterstained with Harris hema- tration of 3 mg/ml and stored in aliquots at 2708C. The
toxylin for one minute and dehydrated with graded etha- protein concentrations were determined by the Bradford
nol and xylene, and the cover slip was mounted with an method (Bio-Rad Protein Assay; Bio-Rad Laboratories,
automatic processor (Tissue-Tek). Hercules, CA, USA) [34].
The number of ED-1–positive interstitial cells was
Electrophoretic mobility shift assay and densitometryquantitated in 10 nonoverlapping cortical fields (3400,
Double stranded NF-kB consensus oligonucleotides (59-measuring 0.075 mm2 each). Images were transferred
AGTTGAGGGGACTTTCCCAGG-39; Promega, Madi-onto a video screen with the computer-assisted image
son, WI, USA) were end labeled with [32P] gATP (Amer-analysis as described earlier in this article. Interstitial
sham Life Science, Sydney, Australia). Unincorporatedcells with chromogen-labeled cytoplasm and a clearly
label was removed with a G-50 sephadex spin column.visible nucleus were marked on the screen, and the total
The binding reaction was performed for 30 minutes at
number per field was counted. The mean number of room temperature and contained 5 mg of nuclear protein
ED-1–positive cells per interstitial field was calculated extract, 2 ml of binding buffer (5 mm MgCl2, 50 mm Tris-
for each section and expressed as cells per mm2. Simi- HCl, 250 mm NaCl, 20% glycerol, 2.5 mm EDTA, 2.5 mm
larly, the number of ED-1–positive cells per glomerulus dithiothreitol, 0.25 mg/ml poly dI.dC), 1 ml 32P-labeled
was counted (3400), and the mean of 20 randomly se- NF-kB probe (50,000 cpm, Cherenkov counting) to a
total volume of 10 ml in distilled water. The reaction waslected glomeruli was determined.
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Fig. 2. Cortical tubulointerstitial injury during adriamycin (ADR) nephrosis. Photomicrographs of periodic acid-Schiff stained cortical sections
obtained from control animals (A) and rats injected with ADR after 7 (B), 14 (C), 21 (D), and 28 days (E; 3250).
stopped by the addition of 1 ml of gel-loading buffer (250 x-ray film (Hyperfilm HP film; Amersham Life Science)
with intensifying screens for three to six hours at 2708C.mm Tris-HCl, pH 7.5, 0.2% bromophenol blue, 40%
glycerol). The DNA-protein complexes were resolved The specificity of the NF-kB electrophoretic mobility
shift assay (EMSA) was determined with reactions thatby electrophoresis on a 10 3 12 cm 7% polyacrylamide
gel (TBE buffer) [35]. The gel was run at 10 V/cm for contained either a negative control (no extract), positive
control (extract), specific competitor (100-fold excess of75 minutes and then dried at 808C with a gel drier. Auto-
radiographs were prepared by exposing the dried gel to unlabeled NF-kB probe), and a nonspecific competitor
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to supershift or reduce the intensity of the complexes
were determined in preliminary experiments.
Measurement of renal cortical malondialdehyde
Reactive oxygen species (ROS) are increased in the
renal cortex of rats with ADR nephrosis [37]. Lipid per-
oxidation, as determined by malondialdehyde (MDA),
has been used as a measure of ROS generation in this
model [37]. Because NAC and PDTC are potent antioxi-
dants [38], their effect on cortical MDA was determined
[39]. The kidney cortex was dissected from the medulla
and was weighed and stored on ice. The tissue was ho-
mogenized in 10% wt/vol containing 1.15% KCl solution
and centrifuged at 3,000 r.p.m. for 10 minutes at 48C.
Four hundred microliters of the supernatant was mixed
with 100 ml 8.1% sodium dodecyl sulfate (SDS), 750 ml
20% aqueous acetic acid, 750 ml 0.8% thiobarbituric acid,
and 100 ml distilled water. The mixture was heated in a
water bath at 908C for 60 minutes and then cooled under
tap water. Five hundred microliters of distilled water
and 2.5 ml of N-butanol:pyridine (15:1 vol/vol) were
added, the mixture vortexed, and then centrifuged at
3000 g for 10 minutes at 48C. The absorbance of theFig. 2. (Continued).
supernatant was measured using a spectrophotometer
(Beckman DU68; Beckman Instruments, Fullerton, CA,
USA) at a wavelength of 532 nm. Samples were mea-(unlabeled Sp1 oligonucleotide). These were added 10
sured in duplicate, and 1,1,3,3-tetramethoxypropane wasminutes before the labeled NF-kB probe, and EMSA used as an external standard. MDA is expressed as nmol
was performed as described earlier in this article. per 100 mg protein. Total protein was assayed by the
Two specific bands could be recognized on the EMSA Biuret method [30], using bovine serum albumin as an
performed from cortical nuclear extracts (Fig. 4). The external standard (Sigma-Aldrich, Sydney, Australia).
density of each band was determined with a laser scan-
ning densitometer (Molecular Dynamics, Sunnyvale, Statistics
CA, USA) and image analysis software (ImageQuaNT, All data are expressed as mean and the sem. Compari-
version 4.1, 1994; Molecular Dynamics) as previously sons between two experimental groups were performed
described [36]. An equally sized box was drawn around using the independent t-test and Mann–Whitney U-test
each band, and the volume density was determined in for parametric and nonparametric data, respectively. Mul-
arbitrary units. The sum of the volume density of both tiple parametric and nonparametric comparisons were
bands for a single sample was used as an indirect measure performed using one-way analysis of variance and the
of NF-kB activation and was expressed as a fold-increase Kruskal–Wallis test. The Shapiro–Wilk test was used to
of the mean NF-kB densitometry of control animals. determine the distribution of the data. The Spearman
To determine the subunit composition of the NF-kB rank correlation coefficient was used to determine the
complexes, supershift analysis was performed using spe- relationship between two variables. Calculations were per-
cific concentrated rabbit antisera that are reactive to formed using statistical software (JMP; SAS institute,
epitopes present on rat p50, p65, or c-Rel (SC-114, Carey, NC, USA) with a Macintosh computer. A P value
SC109, SC-70; Santa Cruz Biotechnologies, Santa Cruz, of less than 0.05 was used to indicate statistical significance.
CA; SC-70 was a gift from Ms. Allison Clegg, Depart-
ment of Immunology, Westmead Hospital). The anti-
RESULTSbodies were added five minutes after the labeled NF-kB
Time course of proteinuria and renal function inprobe and were incubated at room temperature for a
adriamycin nephrosisfurther 15 minutes. As a negative control, nuclear ex-
tracts were incubated with or without an equal dilution All rats injected with ADR developed hypoalbumi-
of normal rabbit IgG (Hunter Antisera, Newcastle, Aus- nemia and heavy proteinuria (Table 1). Ascites was also
tralia). EMSA was performed as described earlier, ex- present in rats examined at day 28. UPV increased tenfold
cept the electrophoresis time was increased to 90 min- at day 7 and reached a peak of 26-fold between day 14
utes. The optimal antibody concentrations (1 mg for p50, to day 28 compared with normal rats (Table 1). The SCr
was reduced slightly in ADR rats between day 7 and2 mg for p65 and c-Rel) and incubation period necessary
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day 21, and this may have been due to a reduction in cal interstitium (Fig. 3D). This increase occurred as early
muscle mass caused by protein loss and catabolism. CCl as day 7 (P 5 0.02) and reached a peak at day 28 (P 5
was approximately 35% lower between day 7 to day 21 0.004) when compared with control animals (control,
and 70% lower on day 28 in ADR rats compared with 36.3 6 7.6; day 7, 71.7 6 6.1; day 14, 117.1 6 6.9; day
control animals (Table 1). 21, 225.4 6 21.6; day 28, 410.8 6 63.4 cells/mm2, P ,
0.0001, one-way ANOVA; Fig. 3D). Interstitial ED-1–
Time course of renal histology and ED-1 infiltration in positive cells were particularly increased around cortical
adriamycin nephrosis tubules that had evidence of tubule cell atrophy and
By light microscopic analysis, the histological changes luminal dilation, and at day 28, focal collections of ED-1–
in ADR rats were dominated by tubulointerstitial injury, positive interstitial cells were present (data not shown).
the severity of which increased progressively in the renal The glomerular changes in ADR rats were minimal
cortex from day 7 to day 28 (Fig. 2). The tubular changes and characterized by a mild increase in mesangial matrix
consisted of tubule cell brush border loss, vacuolization, and occasional dilated capillary loops. There was no evi-
cellular atrophy, and basement membrane hypertrophy. dence of glomerulosclerosis (data not shown). The mean
Focal areas of proteinaceous casts and frankly dilated GCA was similar in all groups (control, 12,236 6 998;
tubules were also present. The interstitial space was ex- day 7, 12,220 6 580; day 14, 12,340 6 725; day 21,
panded, and at day 14, this was due to an increase in 12,060 6 526; day 28, 11,052 6 649 mm2, P 5 NS, one-
mononuclear inflammatory cell infiltration and intersti- way ANOVA) as was the mean GC (control, 53 6 4; day
tial edema (Fig. 2C). By day 28, the cellular contribution 7, 55 6 5; day 14, 57 6 5; day 21, 54 6 1; day 28, 50 6
was more marked. Thickening of tubular basement mem- 3 nuclei per glomerulus, P 5 NS, one-way ANOVA).
branes, neoangiogenesis (not shown), and focal areas of The mean MA was increased in ADR rats (control, 1.7 6
matrix deposition also added to the expanded intersti- 0.4; day 7, 2.7 6 0.7; day 14, 2.3 6 0.7; day 21, 3.6 6 0.7;
tium at this time point (Fig. 2E). day 28, 5.4 6 1.0%, P 5 0.03, one-way ANOVA), but
By morphometric analysis, the diameter of cortical this was significant at only day 28 when compared with
tubules was not different at any time point in ADR the control group (P 5 0.03). The mean number of ED-1–
rats and when compared with control animals (control, positive glomerular cells was not different in ADR rats
42.2 6 1.4; day 7, 41.8 6 1.9; day 14, 42.1 6 1.6; day 21, when compared with control animals (control, 1.7 6 0.3;
44.2 6 3.2; day 28, 38.5 6 1.9 microns, P 5 NS; Fig. 3A). day 7, 1.8 6 0.1; day 14, 1.7 6 0.4; day 21, 2.1 6 0.1; day
The cortical tubule cell height fell progressively in ADR 28, 1.5 6 0.2 cells per glomerular cross-section, P 5 NS,
rats and, by day 14, was significantly less than in control
one-way ANOVA).animals (P 5 0.03). By day 28, tubule cell height was
only 37% (P 5 0.0001) of control values (control, 34.8 6 Time course of cortical nuclear factor-kB activation in
1.2; day 7, 32.7 6 2.7; day 14, 27.6 6 1.9; day 21, 20.4 6 adriamycin nephrosis
1.4; day 28, 12.8 6 1.0 microns, P , 0.0001, one-way
Nuclear factor-kB DNA-binding activities were as-analysis of variance; Fig. 3B). The reduction in tubule
sessed in whole cortical nuclear extracts from normalcell height was due to a combination of brush border
and ADR rats using EMSA and labeled consensusloss and cellular atrophy. In control animals, the mean
NF-kB oligonucleotide. The autoradiographs of thepercentage cortical interstitial volume was approximately
polyacrylamide gels are shown in Figure 4A. The results2%. This value is much lower than that previously esti-
shown were performed during a single assay from themated for relative cortical interstitial volume in rats [40],
same gel and are representative of results obtained ina difference that may be due to the different the method
four individual animals per time point with assays per-of quantitation and definition of interstitial volume used
formed in duplicate. In normal rats, the incubation ofin this study. In rats injected with ADR the percentage
cortical nuclear extracts with labeled consensus NF-kBcortical interstitial volume increased from day 14 (P 5
oligonucleotide produced a slower and faster migrating0.001) and reached a peak at day 28 (P 5 0.002) when
band, designated complex I and complex II, respectivelycompared with control animals (control, 1.9 6 0.4; day 7,
(Fig. 4A, lane 1). The density of both complex I and II2.1 6 0.2; day 14, 7.1 6 1.1; day 21, 12.8 6 2.5; day 28,
increased in parallel in ADR rats (Fig. 4A, lanes 219.9 6 2.6%, P 5 0.0001, one-way ANOVA; Fig. 3C).
through 5) beginning from day 7 (lane 2) and reachingThe number of interstitial monocytes was quantitated
near maximal intensity between day 14 to day 28 (Fig.with ED-1 immunostaining. Sections from normal and
4A, lanes 3 through 5). The mean densitometry (sum ofADR rats that were stained with the negative control
complex I and II) of each group is shown in Figure 5.antibody did not react with chromogen (data not shown).
The specificity of the bands was determined in compe-In the interstitium of normal animals, no cells or an
tition studies (Fig. 4B). The loading of a labeled NF-kBoccasional cell stained positively for the ED-1 antigen
probe alone without any sample produced no bands (Fig.(data not shown). In rats injected with ADR, the number
of ED-1–positive cells increased dramatically in the corti- 4B, lane 1). The incubation of renal cortical nuclear
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Fig. 3. Time course of tubulointerstitial morphometric parameters and ED-1 infiltration during adriamycin nephrosis (days 7, 14, 21 and 28). (A)
Mean cross-sectional tubular diameter. (B) Mean cross-sectional tubule cell height. (C) Mean interstitial volume. (D) Mean number of ED-1–
positive interstitial cells. *P , 0.05 and **P , 0.01, respectively, when compared with the control group; #P , 0.05 when compared to day 14
(N 5 4 per group).
Fig. 4. Nuclear factor-kB activation during
adriamycin (ADR) nephrosis. Nuclear ex-
tracts from renal cortical homogenates were
subjected to EMSA using a 32P-labeled con-
sensus NF-kB oligonucleotide. (A) Autora-
diographs showing the time course of NF-kB
activation in ADR nephrosis and normal rats
(lane 1, control; lane 2, day 7 after ADR; lane
3, day 14 after ADR; lane 4, day 21 after ADR;
lane 5, day 28 after ADR). The samples are
from the same gel and had identical exposure
times. The results are representative of four
individual samples at each time point, and all
assays were performed in duplicate. (B) Com-
petition study (lane 1, NF-kB probe without
nuclear extract; lane 2, nuclear extract from
cortical tissue obtained seven days after injec-
tion with ADR; lane 3, same sample as that in
lane 2 plus 100-fold molar excess of unlabelled
NF-kB probe.
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(slower in migration than the p50 supershifted complex)
could be seen in some samples incubated with the p65
antisera but not at all with the c-Rel antisera. The results
were the same when higher concentrations of p65 and
c-Rel antisera were used or when the incubation period
was increased (overnight at 48C). In comparison, com-
plex II was unaffected by p50-specific antisera but was
partially depleted by the addition of p65-antisera (com-
pare lanes 5 and 7, complex II; Fig. 6). The same result
was obtained for animals at day 14 after ADR (data not
shown). At day 21, the composition of complex I was
the same as that for days 7 to 14 after ADR. In contrast,
complex II also contained c-Rel dimers, because incuba-
tion with c-Rel antisera partially reduced the density of
this band at this time point (Fig. 6, lane 12). The partial
Fig. 5. Densitometric analysis of NF-kB bands (sum of complex I and reduction in the density of complex II with p50 antisera atII; Fig. 4) obtained from animals injected with saline (control) or adria-
the day 21 time point (lane 10) was not seen in repeatedmycin (days 7, 14, 21, and 28). Densitometry was performed on autora-
diographs of simultaneously performed mobility shift assays that were assays, and was probably due to a slight reduction in
developed for the same period of time. The individual bar values are
either the amount of protein or probe that was loadedthe mean of each group. *P , 0.05 and **P , 0.01 when compared
with the control group, respectively (N 5 4 per group). in that particular lane. At day 28, the pattern of subunit
activation was the same as that for day 21 (data not
shown). The results were representative of two to three
individual animals per time point, with experiments re-
extract from an ADR rat at day 7 with labeled NF-kB
peated in duplicate. In summary, NF-kB activation inconsensus probe produced the two bands (Fig. 4B, lane
ADR rats was due to an increase in the nuclear transloca-2), whereas the addition of a 100-fold molar excess of
tion of p50/65 and p50/c-Rel heterodimers that accountunlabeled NF-kB oligonucleotide completely abolished
for complex I. Complex II was partially due to an in-both bands (Fig. 4B, lane 3). The incubation of the sam-
crease in p65- and c-Rel–containing dimers.ple with an irrelevant oligonucleotide (Sp-1) had no ef-
fect (data not shown). The same result was obtained
Correlation between functional parameters,when repeated in a total of three individual samples.
tubulointerstitial histology, and NF-kB activationGel supershift assay was used to determine the subunit
specificity of the activated NF-kB complexes at the vari- The protein excretion rate correlated positively with
ous time points, using specific rabbit antiserum that rec- interstitial volume, interstitial ED-1 cell infiltration, and
ognized epitopes on the p50, p65, and c-Rel subunits NF-kB activation (Table 2). In contrast, there was a
(Fig. 6). The incubation of nuclear extracts with negative negative correlation between protein excretion rate and
control antisera did not cause a supershift of the com- tubule cell height (Table 2). CCl correlated positively with
plexes (Fig. 6, lanes 1, 5, and 9) and was not different mean tubule cell height and correlated negatively with
to that of extracts incubated without any serum (data NF-kB activation, percentage interstitial volume, and
not shown). In normal rats (Fig. 6, lanes 1 through 4), interstitial ED-1 infiltration. Interstitial ED-1 infiltration
constitutional expression of complex I consisted of di- correlated strongly with NF-kB activation, interstitial
mers containing p50, 65, and c-Rel subunits, because volume, and tubule cell height.
incubation with the respective antisera partially reduced
the density of this band. In addition, a supershifted com- Effect of NAC and PDTC on functional parameters
plex could be identified on the proximal part of the lanes and renal lipid peroxidation in ADR rats at day 30
in which the p50 antisera was added (Fig. 6, lanes 2,
To determine whether the inhibition of NF-kB couldparallel with arrow). In comparison, complex II did not
attenuate interstitial monocyte/macrophage infiltration,contain these proteins, as incubation with antisera to
NAC and PDTC were administered to rats with ADRp50, p65, and c-Rel had no effect on the density of this
nephrosis. ADR rats had similar food intake and weightband. In ADR rats at day 7, complex I was almost com-
gain during the study period because they were pair fedpletely abolished by the addition of p50-antisera and a
(data not shown). No abnormalities were noted in thesuper-shifted complex formed (Fig. 6, lane 6). Complex
animals treated with NAC and PDTC, and there was noI was partially reduced by the addition of either p65
antisera and c-Rel antisera. A weak supershifted band mortality in any group during the study period. By de-
Rangan et al: NF-kB in proteinuric renal disease 127
Fig. 6. Supershift assay of EMSA performed
from cortical nuclear extracts. Lanes 1, 5, and
9: nuclear protein extracts obtained from con-
trol animals and animals day 7 and 21 after
adriamycin (ADR), respectively, that were in-
cubated with the negative control, normal rab-
bit serum (NRS). Lanes 2, 6, and 10: Incuba-
tion with the p50 antibody. Lanes 3, 7, 11:
incubation with the p65 antibody. Lanes 4, 8,
and 12: incubation with the c-Rel antibody.
The arrow is in alignment with the super-
shifted p50 band. The results are representa-
tive of two to three animals per time point,
and all assays were performed in duplicate.
Table 2. Correlation between functional parameters, tubulointerstitial histology and NF-kB activation
UpV CCr Tubule cell height Interstitial ED-1
NF-kB densitometry 0.63a 20.53a 20.51 0.67b
Tubule cell height 20.70b 0.71b — 20.89b
Interstitial volume 0.80b 20.66b 20.92b 0.93b
Interstitial ED-1 0.81b 20.70a 20.89b —
The correlation data were determined using the Spearman’s ranked order correlation test in a total of 20 individual animals. Abbreviations are: UpV, 24-hour
urinary protein excretion; CCr, endogenous creatinine clearance.
a P , 0.05
b P , 0.01
Table 3. Effect of N-acetylcysteine (NAC), pyrrolidine dithiocarbamate (PDTC) or vehicle on functional parameters in rats injected with
adriamycin (ADR) or saline (control)
Control ADR1vehicle ADR1NAC ADR 1PDTC
Group Day (N 5 6) (N 5 7) (N 5 8) (N 5 8)
Body wt g 10 328612 270 64a 26964a 27463a
30 396611 274 65a 28164a 27666a
SCr lmol /liter 10 4861 4662 49 62 46 61
30 5261 5663 64 65 54 62
SAlb g /liter 10 3360 22 62a 2361a 2361a
30 3162 17 61a 1661a 1761a
V ml /24 hr 10 2062 2464 17 62 15 62
30 1763 2163 23 63 20 64
UpV mg /24 hr 10 2063 249627a 247626a 226621a
30 1863 585639a 576623a 543655a
Up:cr mg /lmol 10 0.2560.03 3.62 60.41a 3.4460.29a 3.2160.27a
30 0.1760.03 6.66 60.50a 7.0061.28a 7.8361.00a
CCr ml /min 10 1.6860.11 1.5260.07 1.51 60.13 1.53 60.07
ml /min /g kidney wt 30 1.6160.06 0.92 60.13a 0.8460.08a 1.0660.10a
Values are expresses as mean 6 sem. Abbreviations: Body wt, body weight; SCr, serum creatinine; SAlb, serum albumin; V, 24-hour urinary volume; UpV, 24-hour
urinary protein excretion; Up:cr, urinary protein:creatinine ratio. There were no differences in these parameters in ADR rats treated with either vehicle, NAC and
PDTC.
a P , 0.01 when compared to the control group
sign, baseline body weight, UPV, SCr, SAlb, and CCl were Cortical MDA was increased 3.7-fold in rats with ADR
nephrosis in comparison to normal animals (control,similar among all groups with ADR nephrosis (Table 3).
The administration of NAC and PDTC did not alter 38.2 6 4.3; ADR 6 vehicle, 139.6 6 23.9 nmol/100 mg
protein, P 5 0.0004; Fig. 7). Treatment with NAC hadthese parameters at day 30 in comparison to the vehicle-
treated ADR group (Table 3). no effect on lipid peroxidation (138.5 6 19.1, P 5 NS),
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(ADR 6 vehicle, 5.7 6 0.5; ADR 6 NAC, 7.0 6 0.4;
ADR 6 PDTC, 5.2 6 0.5%; P 5 0.05, one way ANOVA).
The mean number of ED-1–positive glomerular cells
was not affected by NAC or PDTC (control, 2.0 6 0.3;
ADR 6 vehicle, 1.9 6 0.3; ADR 6 NAC, 2.2 6 0.7;
ADR 6 PDTC, 2.2 6 0.6 ED-1–positive cells per glomer-
ular cross-section; P 5 NS, Kruskal Wallis test).
Effect of NAC and PDTC on NF-kB activation in
adriamycin rats at day 30
At day 30, vehicle-treated ADR rats had increased
NF-kB activation compared with control animals (Fig.
9A). By densitometric analysis (sum of complex I and
II), this represented a fourfold increase in renal cortical
NF-kB (control, 1.0 6 0.2; ADR 6 vehicle, 4.1 6 0.9-
Fig. 7. Effect of vehicle, N-acetylcysteine (NAC) and pyrrolidine dithio- fold increase above control, P 5 0.02, N 5 6 to 7; Fig. 9B).carbamate (PDTC) on renal cortical malondialdehyde (MDA) at 30 day
In ADR rats treated with NAC, there was a tendency forafter injection with adriamycin (ADR). Control animals received saline.
The individual bar values are the mean of each group. *P , 0.05 when NF-kB activation to be increased further, but the mean
compared to the control group; **P , 0.01 when compared to the densitometry was not statistically significant when com-ADR 1 vehicle group (N 5 6 to 8 per group).
pared with the vehicle-treated group (ADR 6 NAC,
6.5 6 1.5-fold-increase above control, P 5 0.22 when
compared with ADR 1 vehicle group, N 5 8; Fig. 9).
In contrast, PDTC-suppressed NF-kB activation and thewhereas PDTC reduced it by 40% (82.8 6 4.0, P 5 0.02)
in comparison to vehicle-treated ADR rats (Fig. 7). mean densitometry were similar to control animals
(1.1 6 0.3 fold-increase above control, P 5 0.005 when
Effect of NAC and PDTC on renal histology and compared with ADR 1 vehicle group, N 5 8; Fig. 9).
ED-1 infiltration in ADR rats at day 30
As described earlier in this article, ADR rats had in-
DISCUSSIONcreased kidney weight and tubulointerstitial injury com-
The NF-kB transcription factors are critical for thepared with control animals (Table 4). The treatment of
activation of genes involved in immunological, inflam-ADR rats with daily injections of NAC had no effect on
matory, and growth-related processes [20, 21]. The re-kidney weight, tubulointerstitial histology in comparison
sults of this article provide evidence that the activationto the vehicle treated rats (Fig. 8A, C and Table 4). In
of NF-kB could play an important role in the progressioncontrast, PDTC-treated ADR rats had reduced tubuloin-
of cortical tubulointerstitial injury in nonimmune chronicterstitial injury (Fig. 8E). With morphometric analysis,
glomerular disease. NF-kB was increased in cortical nu-PDTC partially prevented the reduction in cross-sec-
clear extracts derived from ADR rats for up to four weekstional tubule cell height and increase in interstitial vol-
after disease induction. This activation was correlatedume that occurred in ADR rats (Table 4).
with the degree of proteinuria and interstitial ED-1 infil-The number of interstitial cells positive for ED-1 anti-
tration and preceded the development of tubule cell atro-gen was increased ninefold in ADR rats compared with
phy. The inhibition of NF-kB with PDTC was associatednormal controls (Table 4 and Fig. 8B). In ADR rats
with significantly reduced tubular injury and interstitialtreated with NAC, the number of interstitial ED-1 posi-
ED-1 infiltration. In contrast, treatment with NACtive cells appeared to be greater than in vehicle-treated
(which did not alter NF-kB activation) had no effect onADR rats, but this was not significant (Table 4). In con-
cortical tubulointerstitial injury in ADR nephrosis.trast, PDTC partially prevented the cortical interstitial
Nuclear factor-kB proteins are activated in a varietyinfiltration with ED-1–positive cells that occurred in
of experimental models of renal inflammatory disease,ADR rats (Table 4 and Fig. 8F).
including antiglomerular basement membrane nephritisThe treatment with PDTC or NAC did not affect the
[41], ureteric obstruction [22, 42], endotoxemia [43], andmean GCA (control, 11,875 6 1084 mm2; ADR 6 vehicle,
immune complex nephritis [23]. Our study shows that this12,216 6 448 mm2; ADR 6 NAC, 11142 6 375 mm2;
also occurs in rats with nonimmune proteinuric tubulo-ADR 6 PDTC, 12,185 6 299 mm2, P 5 NS, one-way
interstitial inflammation. As described previously [22]ANOVA) or mean GC (control, 54 6 3; ADR 6 vehicle,
and confirmed in this study, the EMSA of cortical nuclear54 6 3; ADR 6 NAC, 57 6 2; ADR 6 PDTC, 56 6 4
extracts from normal rats had two specific DNA proteinnuclei per glomerular cross-section, P 5 NS, one-way
ANOVA). NAC caused a slight increase in the MA complexes on gel autoradiographs. In order to characterize
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Table 4. Effect of N-acetylcysteine (NAC), pyrrolidine dithiocarbamate (PDTC) or vehicle on cortical tubulointerstitial morphometric
parameters in rats with adriamycin (ADR) nephrosis
Mean tubule
Number of ED-1 positiveMean tubular cell height
KW KW:BW IV cells in the interstitium
Group N g g/100 g % lm cells /mm2
Control 6 1.2860.05 0.3160.01 3.660.6 42.761.6 28.0 61.4 38.564.0
ADR 7 1.8460.14b 0.6560.05b 18.562.3b 46.862.6 14.6 62.3b 322.7629.3b
ADR1NAC 8 1.6560.07b 0.5760.02b 23.862.5b 44.662.9 15.6 61.2b 369.3660.0b
ADR1PDTC 8 1.3160.10d 0.4460.03b,d 9.461.9a,c 40.664.7 23.261.4a,d 166.769.9b,d
Values are expressed as mean 6 sem.
Abbreviation: IV, percentage interstitial volume.
a P , 0.05 and b P , 0.01, respectively, when compared to the control group
c P , 0.05 and d P , 0.01, respectively, when compared to the ADR 1 vehicle-treated group
the subunit specificity of these DNA-protein complexes, protein excretion and the degree of cortical NF-kB acti-
the gel supershift assay was performed. NF-kB proteins vation. Reactive oxygen intermediates, particularly per-
are composed of at least seven members: NFKB1 (p50/ oxides, are potent stimulants of NF-kB activation [38],
105), NFKB2 (p52/100), c-rel (c-Rel), relA (p65), relB and in this article, the cortical production of lipid perox-
(RelB), v-Rel, and the Drosophilia Rel proteins [20, 21, ides was increased approximately fourfold in ADR rats,
38]. We have focused on p50, p65, and c-Rel because as has been demonstrated previously [37]. Inhibition of
of their known importance as positive transcriptional NF-kB with PDTC was associated with a 41% reduction
regulators and role in the production of proinflammatory in renal lipid peroxidation. The increased local production
mediators [20, 21, 44]. In our study, the slower migrating of tumor necrosis factor-a (TNF-a) and platelet-activating
band in the EMSA from normal rats could be depleted factor in ADR rats could also be involved in the renal
or supershifted with either the p50, p65, and c-Rel anti- activation of NF-kB in this model [15, 20, 21]. Mechanical
bodies, whereas the faster migrating band was unaffected stretch can activate NF-kB in vitro [47], and hence, tubu-
by these antisera. It is possible that the faster migrating lar dilation could contribute to transcription factor acti-
complex could be composed of other known members vation in chronic renal disease models. However, this is
of the NF-kB family. However, in a previous study [22], probably of lesser importance in ADR nephrosis (during
this DNA-protein complex could not be depleted with the time points of this study) and possibly of greater
p52 or RelB-specific antisera either, and it was specu- significance in rats with obstructive uropathy [22, 42].
lated that it may contain novel NF-kB proteins [22]. The sensitive and reproducible method of computer-
After the induction of ADR nephrosis, a significant assisted image morphometric analysis was used to quan-
increase in the activation of NF-kB occurred. This is titate glomerular and tubulointerstitial histology. Using
unlikely to be due to a direct effect of ADR because the this method, a time-dependent increase in tubule cell
concentrations of anthracyclines that induce the cellular atrophy, as determined by the cross-sectional tubule cell
activation of NF-kB are not present in renal tissue be- height, was found in ADR rats. Interestingly, although
yond 72 hours after an in vivo injection [45, 46]. As in there were focal areas of frankly dilated tubules, thenormal rats, the slower migrating band in the EMSA
reduction in tubule cell height was not accompanied byfrom ADR rats consisted of p50/65 and p50/c-Rel hetero-
an increase in mean cortical tubular diameter. However,dimers. However, by day 21 and 28, the faster migrating
we have observed significant tubular dilation with longerband could also be partially depleted with p65- and
term follow-up in an accelerated model of ADR nephro-c-Rel–specific antisera. These results contrast to the pat-
sis [32]. Another important finding of the study was thetern of NF-kB activation in other renal models. In rats
strong correlation between tubule cell atrophy and inter-with ureteric obstruction, the p65 subunit appeared to be
stitial ED-1 infiltration, interstitial volume, proteinuria,less prevalent [22], whereas in rats with immune complex
and CCl. Although it is not possible to infer a cause-nephritis, c-Rel was not present in the activated NF-kB
effect relationship between these parameters, the results[23]. Such differences may be important because in vitro
highlight the importance of tubular injury as an effectorstudies suggest that variations in the subunit specificity
of disease progression in proteinuric tubulointerstitial(which may due to etiological stimulants responsible for
disease. This is corroborated by the extensive data pre-NF-kB activation in the various models) are likely to
sented by Bohle, Mackensen-Haen, and von Gise in hu-determine the selection of genes that are activated [44].
man chronic renal disease [48].Multiple signals can activate NF-kB in cells. In vitro
Nuclear factor-kB is known to regulate the expressionstudies from our laboratory [14] and work by Zoja et al
of chemokines, proinflammatory cytokines, adhesion mol-support the hypothesis that proteinuria could directly
ecules, and complement proteins [20, 21]. Therefore, theinduce NF-kB activation in proximal tubular cells [11].
second aim of this study was to determine whether inhibi-This might be the case in ADR nephrosis because there
was a positive nonlinear correlation between urinary tion of NF-kB could attenuate monocyte infiltration in
Fig. 8. Effect of vehicle, N-acetylcysteine (NAC) and pyrrolidine dithiocarbamate (PDTC) on cortical tubulointerstitial pathology and interstitial ED-1
infiltration at day 30 after injection with adriamycin (ADR). Photomicrographs of period acid-Schiff stained cortical sections (A, C, E) and interstitial
ED-1 immunostaining (B, D, F) obtained from rats injected with ADR and treated with vehicle (A, B), NAC (C, D), or PDTC (E, F; 3250).
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Fig. 9. (A) Autoradiographs of electrophoretic mobility shift assays
showing NF-kB activation in nuclear cortical extracts at day 30 after
injection with saline (control) or adriamycin (ADR). Rats with ADR
nephrosis were treated either with vehicle, N-acetylcysteine (NAC), or
pyrrolidine dithiocarbamate (PDTC). Each lane represents a sample
from an individual animal, and assays for all animals from each group
were performed simultaneously. The results shown are representative
of experiments performed in six to eight individual samples per group,
which were done in duplicate. (B) Densitometric analysis of NF-kB
bands (sum of complexes I and II; Fig. 4) in the experimental groups.
Densitometry was performed on autoradiographs of simultaneously
performed mobility shift assays that were developed for same period
of time. The individual bar values are the mean of each group. *P ,
0.05 when compared with the control group; **P , 0.05 when compared
to the ADR 1 vehicle group (N 5 6 to 8 per group).
ADR rats. For this purpose, we used NAC and PDTC, PDTC can inhibit NF-kB DNA binding through a pro-
oxidant effect [50]. Moreover, the disparity between thewhich inhibit NF-kB activation both in vitro and in vivo
[25–27]. reduction in lipid peroxidation and NF-kB activation
in this study also suggests that antioxidant-independentChronic treatment of ADR rats with PDTC dramati-
cally reduced the cortical activation of NF-kB such that mechanisms could be involved in this model. PDTC is
a potent metal chelator [24, 38, 50], can interact withthe mean densitometry was similar to normal control
animals. This complete inhibition was achieved despite thiol groups [50], and is capable of affecting the activity of
other transcription factors [51]. The interactions betweenPDTC being administered beyond a time point when
NF-kB was already activated, demonstrating that this these effects and the inhibition of NF-kB have not been
investigated in this study. Therefore, it is not possible toagent can be effective in both the prevention and termi-
nation of NF-kB activation in chronic disease. To our infer from the our data that PDTC was a direct and
specific inhibitor of NF-kB in this model.knowledge, this is the first time that this has been demon-
strated with PDTC in an in vivo model. Pyrrolidine dithiocarbamate reduced the accumula-
tion of ED-1–positive cells within the cortical interstitialThe mechanisms by which PDTC inhibited NF-kB in
this model are not known. The critical step that allows space by 48% in nephrotic rats. Similar to these results,
the continuous administration of PDTC reduced leuko-NF-kB dimers to enter the nucleus is the degradation of
IkB (a family of inhibitory proteins bound to NF-kB cyte-induced chemoattraction in alcohol-induced cere-
bral inflammation [52]. Many NF-kB regulated geneswithin the cytosol), an event that may be triggered by
the generation of intracellular reactive oxygen interme- play an important role in mediating leukocyte chemo-
taxis and activation [20, 21]. The inhibition of NF-kBdiates, depending on the type of cell and stimulus [20,
21, 38, 49]. PDTC is a potent antioxidant and, in this with PDTC reduced albumin and IgG-induced RANTES
(a CC chemokine) expression in LLC-PK1 cells [11].study, reduced renal lipid peroxidation [38]. However,
it remains uncertain whether this and/or other effects are PDTC also suppressed hypoxia-stimulated intercellular
adhesion molecule-1 (ICAM-1) expression in culturedresponsible for its ability to inhibit NF-kB. For example,
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human proximal tubular cells [53]. In vivo, PDTC re- tial injury, PDTC treatment was not accompanied by an
improvement in CCl. In micropuncture studies, O’Don-duced the glomerular expression of monocyte chemo-
nell et al showed that the single-nephron glomerularattractant protein-1 (MCP-1), interleukin-1b (IL-1b),
filtration rate was reduced in ADR nephrosis as resultand ICAM-1 in experimental anti-glomerular basement
of a decrease in renal plasma flow and glomerular ultra-membrane nephritis [41]. Diethyldithiocarbamate (a di-
filtration coefficient (Kf) [60]. The reasons for the reduc-thiocarbamate related to PDTC) reduced NF-kB and
tion in Kf in ADR nephrosis are not known but couldthe transcription of IL-1b, TNF-a, IL-6, and inducible
include altered plasma protein concentration [61], glo-nitric oxide synthase (iNOS) in rats with ischemic myo-
merular structure [62], and tubuloglomerular feedbackcardium [54]. However, the effects of PDTC on NF-
[48]. The persistence of these abnormalities in PDTC-kB–regulated genes are complex. In endothelial cells,
treated ADR rats may explain why CCl was not normal-PDTC reduced vascular cell adhesion molecule-1 but
ized. It remains to be determined whether long-termnot ICAM-1, although both genes are regulated by NF-
PDTC treatment could reduce interstitial fibrosis andkB [20, 55]. Moreover, in lipopolysaccharide (LPS)-stim-
prevent a further decline in renal function in this model.ulated rabbit alveolar macrophages, PDTC paradoxi-
Like PDTC, the effect of NAC may be due to itscally increased TNF-a, despite inhibiting NF-kB [56]. In
antioxidant properties as well as other, possibly unique,
ADR nephrosis, we have previously shown that there is distal effects on the NF-kB signal transduction pathway
a time-dependent increase in the transcription of MCP- [25, 26, 63]. However, in this study, twice daily intraperi-
1, TNF-a, and IL-10 in whole renal cortex (unpublished toneal injections of NAC for 16 days failed to inhibit
observation), yet in separate studies, we found that NF-kB in ADR rats. Moreover, in NAC-treated ADR
PDTC failed to attenuate whole cortical expression of rats, there was a tendency for increased cortical activa-
MCP-1 and TNF-a but reduced IL-10. In vitro PDTC tion of NF-kB, interstitial ED-1 infiltration, and mesan-
reduced LPS-induced MCP-1, TNF-a, and IL-10 in rat gial matrix deposition, although this was not statistically
proximal tubular cells, suggesting that these effects may significant. Similar to these results, NAC, when adminis-
be cell and stimulus specific (manuscript submitted for tered once daily as an intraperitoneal injection for 14
publication). days, worsened alveolar epithelial cell damage in rats
The reduction in ED-1–positive interstitial cells in with chronic hyperoxia [64]. NAC is also known to in-
ADR rats by PDTC could also be explained by an in- crease NF-kB activation in vitro in some cell types, an
crease in macrophage apoptosis, as has been demon- effect that may be due to auto-oxidation [65]. However,
strated in vitro [57]. In contrast, when cultured rat proxi- in contrast, NAC is protective in experimental models
of acute tubular necrosis [66, 67, and Note Added inmal tubular cells are exposed to PDTC for 24 hours at
Proof] and suppressed renal NF-kB activation in LPS-NF-kB inhibitory concentrations, an increase in the rate
induced glomerulonephritis. Furthermore, 1% NAC inof apoptosis was not observed (unpublished observa-
drinking water provided ad libitum (for up to 5 days) totion). Additionally, we have not investigated in this study
rats with nonproteinuric tubulointerstitial injury signifi-whether PDTC could affect monocyte differentiation
cantly reduced cortical NF-kB, activation, MCP-1 tran-and proliferation. The latter could be mediated by inhibi-
scription, and interstitial monocyte infiltration and (ab-tion of NF-kB–regulated colony-stimulating factors [20,
stract; Morrissey, Proceedings of the Extramural Grant21]. Finally, NF-kB–independent mechanisms are also
Program Annual Meeting, p74, 1998). The reasons forlikely to play a role in monocyte chemotaxis, differentia-
the discrepancy with our study are not certain, but maytion, and survival in ADR nephrosis because interstitial
include differences in the dose and route of drug adminis-ED-1 infiltration was still increased fourfold in PDTC-
tration, the duration of treatment, and finally that distincttreated rats compared with normal control animals.
pathways are responsible for NF-kB activation in ADRPyrrolidine dithiocarbamate partially attenuated the
nephrosis and these may be NAC-resistant.morphological features of tubular injury in ADR ne-
The cellular origin of the activated NF-kB proteins in
phrosis. This may have been due to a reduction in macro- ADR nephrosis is not known. Infiltrating macrophages
phage infiltration because in the time course study, the may be a potential source because NF-kB activation was
onset of tubule cell atrophy was preceded by interstitial correlated with the number of ED-1–positive interstitial
ED-1 infiltration. PDTC could also have directly attenu- cells. However, NF-kB was already increased approxi-
ated tubular damage through its effects as an antioxidant mately fourfold by day 7 (when there was only a mild
[38], metal chelator [24], and possible inhibition of NF- increase in the number of interstitial cells), suggesting that
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